Technical / White Paper

Single-Pass TFF and the New Era of Bioprocessing

Format: PDF file | Document type: Technical / White Paper | Promoted Content

This content is provided by Pall Biotech, and any views and opinions expressed do not necessarily reflect those of www.biopharma-reporter.com

Single-Pass TFF and the New Era of Bioprocessing

Learn how single-pass tangential flow filtration (SPTFF) technology is revolutionizing current and future bioprocessing platforms with its implementations in biotech, vaccine and plasma industries. Adopting SPTFF at process development (PD), pilot, clinical and commercial manufacturing scales has major advantages over conventional approaches. Key benefits include flexible manufacturing, reduced processing volumes, high product recoveries and increased yield, as well as major savings in capital expenditures. SPTFF also enables disposable and/or single-use technology utilization.

Related resources from Pall Biotech

Show more

Supplier info centre